NM_001105206.3:c.3283-15C>T

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001105206.3(LAMA4):​c.3283-15C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.736 in 1,594,090 control chromosomes in the GnomAD database, including 436,102 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.77 ( 46181 hom., cov: 33)
Exomes 𝑓: 0.73 ( 389921 hom. )

Consequence

LAMA4
NM_001105206.3 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: -0.472
Variant links:
Genes affected
LAMA4 (HGNC:6484): (laminin subunit alpha 4) Laminins, a family of extracellular matrix glycoproteins, are the major noncollagenous constituent of basement membranes. They have been implicated in a wide variety of biological processes including cell adhesion, differentiation, migration, signaling, neurite outgrowth and metastasis. Laminins are composed of 3 non identical chains: laminin alpha, beta and gamma (formerly A, B1, and B2, respectively) and they form a cruciform structure consisting of 3 short arms, each formed by a different chain, and a long arm composed of all 3 chains. Each laminin chain is a multidomain protein encoded by a distinct gene. Several isoforms of each chain have been described. Different alpha, beta and gamma chain isomers combine to give rise to different heterotrimeric laminin isoforms which are designated by Arabic numerals in the order of their discovery, i.e. alpha1beta1gamma1 heterotrimer is laminin 1. The biological functions of the different chains and trimer molecules are largely unknown, but some of the chains have been shown to differ with respect to their tissue distribution, presumably reflecting diverse functions in vivo. This gene encodes the alpha chain isoform laminin, alpha 4. The domain structure of alpha 4 is similar to that of alpha 3, both of which resemble truncated versions of alpha 1 and alpha 2, in that approximately 1,200 residues at the N-terminus (domains IV, V and VI) have been lost. Laminin, alpha 4 contains the C-terminal G domain which distinguishes all alpha chains from the beta and gamma chains. The RNA analysis from adult and fetal tissues revealed developmental regulation of expression, however, the exact function of laminin, alpha 4 is not known. Tissue-specific utilization of alternative polyA-signal has been described in literature. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Aug 2011]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant 6-112136269-G-A is Benign according to our data. Variant chr6-112136269-G-A is described in ClinVar as [Benign]. Clinvar id is 44375.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-112136269-G-A is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.857 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LAMA4NM_001105206.3 linkc.3283-15C>T intron_variant Intron 24 of 38 ENST00000230538.12 NP_001098676.2 Q16363A0A0A0MQS9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
LAMA4ENST00000230538.12 linkc.3283-15C>T intron_variant Intron 24 of 38 1 NM_001105206.3 ENSP00000230538.7 A0A0A0MQS9

Frequencies

GnomAD3 genomes
AF:
0.775
AC:
117793
AN:
152052
Hom.:
46118
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.865
Gnomad AMI
AF:
0.729
Gnomad AMR
AF:
0.812
Gnomad ASJ
AF:
0.757
Gnomad EAS
AF:
0.864
Gnomad SAS
AF:
0.872
Gnomad FIN
AF:
0.734
Gnomad MID
AF:
0.677
Gnomad NFE
AF:
0.706
Gnomad OTH
AF:
0.765
GnomAD3 exomes
AF:
0.775
AC:
193138
AN:
249240
Hom.:
75707
AF XY:
0.773
AC XY:
104198
AN XY:
134824
show subpopulations
Gnomad AFR exome
AF:
0.872
Gnomad AMR exome
AF:
0.873
Gnomad ASJ exome
AF:
0.765
Gnomad EAS exome
AF:
0.854
Gnomad SAS exome
AF:
0.863
Gnomad FIN exome
AF:
0.743
Gnomad NFE exome
AF:
0.702
Gnomad OTH exome
AF:
0.753
GnomAD4 exome
AF:
0.732
AC:
1056085
AN:
1441920
Hom.:
389921
Cov.:
28
AF XY:
0.736
AC XY:
528704
AN XY:
718520
show subpopulations
Gnomad4 AFR exome
AF:
0.867
Gnomad4 AMR exome
AF:
0.866
Gnomad4 ASJ exome
AF:
0.759
Gnomad4 EAS exome
AF:
0.862
Gnomad4 SAS exome
AF:
0.858
Gnomad4 FIN exome
AF:
0.740
Gnomad4 NFE exome
AF:
0.707
Gnomad4 OTH exome
AF:
0.747
GnomAD4 genome
AF:
0.775
AC:
117918
AN:
152170
Hom.:
46181
Cov.:
33
AF XY:
0.778
AC XY:
57880
AN XY:
74386
show subpopulations
Gnomad4 AFR
AF:
0.865
Gnomad4 AMR
AF:
0.812
Gnomad4 ASJ
AF:
0.757
Gnomad4 EAS
AF:
0.864
Gnomad4 SAS
AF:
0.871
Gnomad4 FIN
AF:
0.734
Gnomad4 NFE
AF:
0.706
Gnomad4 OTH
AF:
0.768
Alfa
AF:
0.736
Hom.:
20809
Bravo
AF:
0.779
Asia WGS
AF:
0.891
AC:
3095
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
-
PreventionGenetics, part of Exact Sciences
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Sep 16, 2011
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

-
Clinical Genetics, Academic Medical Center
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Apr 04, 2023
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Nov 22, 2013
GeneDx
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Dilated cardiomyopathy 1JJ Benign:4
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance: Benign
Review Status: no assertion criteria provided
Collection Method: clinical testing

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Aug 19, 2021
Genome-Nilou Lab
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Sep 21, 2015
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.86
CADD
Benign
0.85
DANN
Benign
0.53

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs2032568; hg19: chr6-112457471; COSMIC: COSV57893892; API